FDA Expands Symdeko Indications for Pediatric Patients with Cystic Fibrosis - Drug Topics

FDA Expands Symdeko Indications for Pediatric Patients with Cystic Fibrosis  Drug Topics

Symdeko (a combination of tezacaftor/ivacaftor) tablets, from Vertex Pharmaceuticals, was approved to treat pediatric patients ages 6 years and older with cystic ...